Abstract

We aimed to identify plasma and urine metabolites altered by the Dietary Approaches to Stop Hypertension (DASH) diet in a post-hoc analysis of a pilot feeding trial. Twenty adult participants with un-medicated hypertension consumed a Control diet for one week followed by 2 weeks of random assignment to either Control or DASH diet. Non-missing fasting plasma (n = 56) and 24-h urine (n = 40) were used to profile metabolites using untargeted gas chromatography/mass spectrometry. Linear models were used to compare metabolite levels between the groups. In urine, 19 identifiable untargeted metabolites differed between groups at p < 0.05. These included a variety of phenolic acids and their microbial metabolites that were higher during the DASH diet, with many at false discovery rate (FDR) adjusted p < 0.2. In plasma, eight identifiable untargeted metabolites were different at p < 0.05, but only gamma-tocopherol was significantly lower on DASH at FDR adjusted p < 0.2. The results provide insights into the mechanisms of benefit of the DASH diet.

Highlights

  • The Dietary Approaches to Stop Hypertension (DASH) diet emphasizes consumption of fruits, vegetables, low-fat dairy, whole grains, fish, poultry, and nuts, while limiting red meat, sweets, and sugar-containing beverages [1]

  • Clinical parameters including changes in blood pressure, endothelial function, pulse wave velocity, and plasma nitric oxide levels were reported in the original study

  • Consumption of DASH diet resulted in significant reductions of blood pressure starting at the end of week one and end of week two [6]

Read more

Summary

Introduction

The Dietary Approaches to Stop Hypertension (DASH) diet emphasizes consumption of fruits, vegetables, low-fat dairy, whole grains, fish, poultry, and nuts, while limiting red meat, sweets, and sugar-containing beverages [1]. DASH reduces systolic blood pressure (BP) by an average of 5.2 mmHg over durations of 2–24 weeks [2]. Observational studies suggest that DASH may reduce the risks of atherosclerotic cardiovascular disease, stroke, diabetes, and kidney disease [3,4]. The mechanism of benefit of the DASH diet is poorly understood. Metabolomics phenotyping can help characterize the changes in body chemistry following a dietary intervention, such as DASH, and identify potential mechanisms of benefit [5]. Understanding the potential mechanisms of DASH using informative biomarkers could help to fine-tune

Objectives
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.